EDGEWISE THERAPEUTICS INC (EWTX)
US28036F1057 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -105.85M | -100.16M | -67.64M | -42.81M | -17.12M | |||
| Depreciation Amortization | 1.82M | 1.55M | 370.00K | 270.00K | 190.00K | |||
| Change In Working Capital | -1.89M | -1.56M | 4.09M | 4.63M | 1.95M | |||
| Other non cash items | 8.19M | 8.22M | 10.55M | 4.40M | 350.00K | |||
| OPERATING CASH FLOW | -97.72M | -91.95M | -52.64M | -33.51M | -14.63M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.67M | -5.75M | -5.55M | -670.00K | -200.00K | |||
| Other Investing Activity | -212.79M | 108.63M | -65.03M | -241.56M | -24.18M | |||
| INVESTING CASH FLOW | -214.46M | 102.89M | -70.58M | -242.23M | -24.38M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 294.38M | 53.33M | 129.89M | 186.51M | 120.28M | |||
| Other Financing Activity | N/A | -165.00K | -250.00K | -120.00K | N/A | |||
| FINANCING CASH FLOW | 294.22M | 53.17M | 129.64M | 186.38M | 120.28M | |||
| CHANGE IN CASH | -17.96M | 64.10M | 6.42M | -89.36M | 81.27M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -97.72M | -91.95M | -52.64M | -33.51M | -14.63M | |||
| Capital Expenditure | -1.67M | -5.75M | -5.55M | -670.00K | -200.00K | |||
| FREE CASH FLOW | -99.39M | -97.69M | -58.19M | -34.18M | -14.83M | |||
All data in USD